# No Barrier AI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/no-barrier-ai

- Industry: Healthcare IT
- Headquarters: San Francisco, US
- Website: www.nobarrier.ai
- Total disclosed funding: $2.7M
- Latest round: Seed (Nov 17, 2025)
- Investors on record: 4

## About

Based in the US, No Barrier AI, Inc. provides innovative AI-driven medical interpretation services to bridge communication gaps between healthcare providers and patients who have limited English proficiency.Founded in 2023 and headquartered in San Francisco, US, No Barrier AI, Inc. specializes in AI-powered medical interpretation. The company secured USD 2.7 mn in Seed funding in November 2025, co-led by Esplanade HealthTech Ventures, Rock Health, Arkin Holdings, and Fusion. This marks their first deal, with a total amount raised of USD 2.7 mn.No Barrier specializes in AI-driven medical interpretation services designed to enhance communication between healthcare providers and patients with limited English proficiency. Their core offering is a mobile application that provides instant access to medical interpretation across over 40 languages, aiming to eliminate the delays and costs traditionally associated with human interpreters. By leveraging advanced artificial intelligence, the service enables healthcare professionals to engage in fluent conversations with patients in real-time, thereby improving the overall patient experience and ensuring accurate understanding of medical terminology. No Barrier's platform caters primarily to hospitals, clinics, and private practices, enabling a seamless integration of interpretation services within diverse healthcare environments. The company has made significant inroads into markets throughout the United States and internationally, addressing the urgent need for effective language support in healthcare settings.The revenue model of No Barrier is predicated on a subscription-based approach for its medical interpretation services, allowing healthcare providers to access their AI platform for a recurring fee. This structure supports both B2B transactions and direct partnerships with healthcare institutions, providing them with a flexible and cost-effective solution for language interpretation. Clients engage with the service through customized plans tailored to their specific usage needs, which may include tiered pricing for varying levels of access or volume of interpretation services used. The emphasis on cost reduction, demonstrated by a reported 70% decrease compared to traditional services, positions No Barrier as an attractive option for healthcare providers looking to streamline their operations while ensuring high-quality patient interactions. As part of their offerings, the company promotes its flagship application, which has garnered positive feedback for its user-friendly interface and efficiency in overcoming language barriers in medical contexts.No Barrier AI, Inc. plans to utilize its most recent Seed round funding of USD 2.7 mn to expand its real-time AI medical interpretation offerings in hospitals, connect with electronic health records, and support wider clinical use. The company aims to introduce new products that enhance their existing platform and plans to expand into additional markets by the end of 2026.

## Funding rounds

- Seed, Nov 17, 2025, $2.7M — Rock Health, Arkin Capital, Fusion, Esplanade HealthTech Ventures

## Investors

- Rock Health (https://capitalatlas.ai/funds/rock-health) — Seed
- Arkin Capital (https://capitalatlas.ai/funds/arkin-capital) — Seed
- Fusion (https://capitalatlas.ai/funds/fusion) — Seed
- Esplanade HealthTech Ventures (https://capitalatlas.ai/funds/esplanade-healthtech-ventures) — Seed